Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Allogene Therapeutics (ALLO) Gains from Investment Securities (2019 - 2025)

Allogene Therapeutics (ALLO) has disclosed Gains from Investment Securities for 7 consecutive years, with -$1.5 million as the latest value for Q3 2025.

  • Quarterly Gains from Investment Securities rose 74.95% to -$1.5 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $6.0 million through Sep 2025, up 191.03% year-over-year, with the annual reading at $2.4 million for FY2024, N/A changed from the prior year.
  • Gains from Investment Securities hit -$1.5 million in Q3 2025 for Allogene Therapeutics, down from $1.9 million in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $28.2 million in Q2 2022 to a low of -$28.2 million in Q3 2022.
  • Historically, Gains from Investment Securities has averaged $1.1 million across 5 years, with a median of $100000.0 in 2023.
  • Biggest YoY gain for Gains from Investment Securities was 20421.58% in 2022; the steepest drop was 8604.53% in 2022.
  • Year by year, Gains from Investment Securities stood at $16.7 million in 2021, then crashed by 119.21% to -$3.2 million in 2022, then rose by 6.57% to -$3.0 million in 2023, then skyrocketed by 300.0% to $6.0 million in 2024, then plummeted by 125.05% to -$1.5 million in 2025.
  • Business Quant data shows Gains from Investment Securities for ALLO at -$1.5 million in Q3 2025, $1.9 million in Q2 2025, and -$425000.0 in Q1 2025.